Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
abiraterone (zytiga) (2 trials)
methylprednisolone (medrol) (1 trial)
autologous dendritic cells (1 trial)
carboplatin (paraplatin) (1 trial)
cisplatin (platinol) (1 trial)
degarelix acetate (firmagon) (1 trial)
paclitaxel (taxol) (1 trial)
pemetrexed (alimta) (1 trial)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Lung Neoplasms (Phase 2)
Prostatic Neoplasms (Phase 3)
Trials (3 total)
Trial APIs (8 total)